Gateway for:

Member Countries

Projects

#A-2140Phage therapy against MDR Salmonella infections

Targeted elimination of multidrug-resistant (MDR) Salmonella by bacteriophages

#G-1021Transmission of Water-Borne Infections

Study of Transmission of Water-Borne Infections by Application of Computer Modeling (GIS) and Field Experiments Implemented with Tracer Phages

#G-1028Bacteriophages Against Intestinal Infections

Bacteriophages as an Alternative Remedy Against Multidrug Resistant Bacteria (Salmonella, Shigella, Pathogenic E.coli) Causing Intestinal Infections in Humans

#G-1037Bacteriophages for Treatment Cow Metritis and Endometritis

Prolonged Acting, High Effective Bacteriophage Preparation for Treatment of Cow Metritis and Endometritis

#G-1064Properties of Phages for Production of Preparation

Selection of Active Phages against the Y. enterocolitica and Y. enterocolitica Like Strains and Investigation of their Molecular-Biological Properties with an Aim to Construct Medicinal-Prophylactic Polyvalent Preparation

#G-1242Purulent Infections of Neonates and Prevention with Bacteriophages

Purulent Infections of Neonates and Prevention with Bacteriophages

#G-1369Bcteriophages against Chronic Prostatitis Microflora

Microflora of Inflammatory Process in Chronic Prostatitis and Urogenital Tracts in Men and Phage Therapy Prospects

#G-1556Vaccine based on Phage Lysis Products

New Model of Vaccine Development Using Bacteriophages

#G-1666Bacteriophage Composite against Dental Infections

Development of a New Phage Composite Targeted to Prevent and Treat Mixed Infections

#G-1735Interaction between Bacteriophages and Antibiotics

Study of Interactions between Antibiotics And Bacteriophages for Strains Isolated From Patients During the Treatment of Suppurative Infections

#G-2055Phage-probiotic

Development of the phage-probiotic complex for veterinary use

#G-416Anti-Anthrax Immunoglobulin

Elaboration of an Improved Technology of Obtaining Heterogeneous Anti-Anthrax Immunoglobulin for Urgent Treatment and Prevention of Anthrax in Bacteriological Contamination of the Places of Distribution of the Troops, Firing Grounds and Inhabited Localiti

#G-416.2Anti-Anthrax Immunoglobulin

Elaboration of an Improved Technology of Obtaining Heterogeneous Anti-Anthrax Immunoglobulin for Urgent Treatment and Prevention of Anthrax in Bacteriological Contamination of the Places of Distribution of the Troops, Firing Grounds and Inhabited Localiti

#G-416.3Anti-Anthrax Immunoglobulin

Elaboration of an Improved Technology for Obtaining Heterogeneous Anti-Anthrax Immunoglobulin for Urgent Treatment and Prevention of Anthrax in Bacteriological Contamination of the Places of Distribution of the Troops, Firing Grounds and Inhabited Localit

#G-510Bacteriophages Against Infectious Diseases

Bacteriophages for the Treatment of Infectious Diseases Caused by Antibiotic-Resistant Bacterial Strains of Staphylococcus Aureus and Pseudomonas Aeruginosa

#G-589Controlled-Release Drugs with Bacteriophages

Sustained/Controlled-Release Drug Devices Containing Bacteriophages Based on New Biodegradable Poly (ester amide)s

#G-591Tuberculosis Bacteriophage

Tuberculosis Bacteriophage: Development of Obtainment and Application Methods

#G-824Bacteriophages in Different Medicinal Forms

Different Medicinal Forms of Bacteriophages for Treatment and Prevention of Bacterial Infections Induced by the Genera of Staphylococcus and Streptococcus